3,906 Shares in Align Technology, Inc. $ALGN Bought by AXQ Capital LP

AXQ Capital LP purchased a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,906 shares of the medical equipment provider’s stock, valued at approximately $489,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Align Technology by 4.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,222 shares of the medical equipment provider’s stock valued at $1,624,000 after buying an additional 469 shares in the last quarter. Focus Partners Wealth grew its position in Align Technology by 5.2% during the first quarter. Focus Partners Wealth now owns 3,062 shares of the medical equipment provider’s stock valued at $486,000 after acquiring an additional 151 shares during the last quarter. Sivia Capital Partners LLC purchased a new position in shares of Align Technology during the second quarter worth approximately $204,000. Ethic Inc. bought a new stake in shares of Align Technology in the 2nd quarter worth approximately $234,000. Finally, Asset Management One Co. Ltd. boosted its stake in shares of Align Technology by 2.9% in the 2nd quarter. Asset Management One Co. Ltd. now owns 32,533 shares of the medical equipment provider’s stock valued at $6,159,000 after purchasing an additional 909 shares in the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP John Morici sold 7,969 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total value of $1,508,611.39. Following the completion of the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at $1,559,346.47. This represents a 49.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.66% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

ALGN has been the topic of a number of analyst reports. Leerink Partners boosted their price target on shares of Align Technology from $210.00 to $225.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Wall Street Zen upgraded Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, January 3rd. Mizuho boosted their target price on Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Needham & Company LLC restated a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Finally, Evercore lifted their price target on Align Technology from $180.00 to $200.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $195.58.

Key Stories Impacting Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Zacks published a “strong value” read on ALGN, highlighting favorable Style Scores that may attract value-oriented investors and lift demand. Read More.
• Positive Sentiment: Zacks also featured ALGN as a top momentum stock and noted it is outpacing many medical peers this year — commentary that can support momentum-driven buying and analyst optimism. Read More. · Read More.
• Positive Sentiment: Product/market expansion: Align rolled out the iTero Lumina intraoral scanner in Saudi Arabia at a major dental conference — a commercial expansion that supports international growth and device revenue potential. Read More.
• Positive Sentiment: Market commentary: Barchart summarized Wall Street’s generally favorable stance on Align, citing improving momentum and steady execution — an analyst tone that tends to support multiple expansion. Read More.
• Neutral Sentiment: Short-interest report appears to contain erroneous/empty data (shows 0 shares / NaN change and 0 days to cover); it offers no actionable signal to the market in its current form.
• Negative Sentiment: Insider activity: An Align EVP sold about $1.5M of stock — a disclosure that can create short-term selling pressure or caution among some investors. Read More.
• Negative Sentiment: Short-term performance note: MarketWatch flagged that ALGN recently underperformed peers on a particular trading day, which may weigh on sentiment for short-term traders. Read More.

Align Technology Stock Performance

Shares of ALGN stock opened at $185.53 on Wednesday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $208.30. The firm has a market cap of $13.31 billion, a P/E ratio of 32.78, a P/E/G ratio of 1.99 and a beta of 1.84. The business’s 50 day moving average price is $170.56 and its 200-day moving average price is $150.07.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.30. The company had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.44 earnings per share. As a group, equities analysts predict that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.